Research

Update on the role of pharmaceutical-grade chondroitin sulfate (CS) in the symptomatic management of knee osteoarthritis. 

In this literature review from 2019, the authors summarized the most recent findings on the efficacy and safety of CS in OA.  Based on the results of studies presenting a low risk of bias, the most recent meta-analysis shows that only the pharmaceutical-grade CS may be considered as an appropriate background treatment for the management of knee OA. 

References:

Honvo G, Bruyère O, Reginster JY. Update on the role of pharmaceutical-grade chondroitin sulfate in the symptomatic management of knee osteoarthritis. Aging Clin Exp Res. 2019;31(8):1163-1167. doi:10.1007/s40520-019-01253-z https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661017/ 

Ingredient in this research

Let’s keep in touch

Don’t worry we only send updates monthly on offers, product changes, and new opportunities for you.

Due to increased order volumes, some orders may experience shipping delays. Thank you for your patience and understanding.
×
Why Choose to Subscribe and Save?
  • Automatically re-order your favorite products on your schedule.
  • Easily change the products or shipping date for your upcoming Scheduled Orders.
  • If you decide a subscription is not for you, it can be cancelled after 2 renewals.